Ying Di

914 total citations
33 papers, 654 citations indexed

About

Ying Di is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Ying Di has authored 33 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Hematology. Recurrent topics in Ying Di's work include Platelet Disorders and Treatments (9 papers), Lymphatic System and Diseases (6 papers) and Virus-based gene therapy research (5 papers). Ying Di is often cited by papers focused on Platelet Disorders and Treatments (9 papers), Lymphatic System and Diseases (6 papers) and Virus-based gene therapy research (5 papers). Ying Di collaborates with scholars based in United Kingdom, China and Germany. Ying Di's co-authors include Steve P. Watson, Leonard W. Seymour, Julie Rayes, Kerry D. Fisher, Siân Lax, Surasak Wichaiyo, Kassiani Skordilis, Stephanie K. Watson, Beata Grygielska and Stuart W. Smith and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Ying Di

33 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying Di United Kingdom 16 294 173 138 136 116 33 654
Sven Stengel Germany 15 433 1.5× 96 0.6× 69 0.5× 74 0.5× 188 1.6× 30 834
Xiaoming Wu China 15 303 1.0× 135 0.8× 26 0.2× 79 0.6× 101 0.9× 46 709
Diana Saleiro United States 16 362 1.2× 238 1.4× 93 0.7× 78 0.6× 306 2.6× 30 813
Christoffer Soendergaard Denmark 15 309 1.1× 255 1.5× 99 0.7× 299 2.2× 97 0.8× 21 879
Mee‐Young Ahn South Korea 18 565 1.9× 116 0.7× 90 0.7× 35 0.3× 110 0.9× 28 844
Yueping Sun China 12 330 1.1× 192 1.1× 84 0.6× 28 0.2× 257 2.2× 20 718
Xue-Chun Lu China 12 233 0.8× 182 1.1× 75 0.5× 23 0.2× 209 1.8× 39 560
Tsuyako Saito Japan 10 356 1.2× 191 1.1× 77 0.6× 37 0.3× 112 1.0× 37 722
Αthanasios Mavropoulos Greece 17 243 0.8× 121 0.7× 64 0.5× 48 0.4× 518 4.5× 40 1.0k

Countries citing papers authored by Ying Di

Since Specialization
Citations

This map shows the geographic impact of Ying Di's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Di with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Di more than expected).

Fields of papers citing papers by Ying Di

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Di. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Di. The network helps show where Ying Di may publish in the future.

Co-authorship network of co-authors of Ying Di

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Di. A scholar is included among the top collaborators of Ying Di based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Di. Ying Di is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Di, Ying, et al.. (2023). Thromboelastography parameters in chronic viral liver disease and liver resection: a retrospective study. Singapore Medical Journal. 65(8). 438–443. 1 indexed citations
2.
Di, Ying, María N. Barrachina, Todd H. Mize, et al.. (2022). Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet Agonist. Thrombosis and Haemostasis. 122(8). 1361–1368. 6 indexed citations
3.
Yan, Yan, Jie Qu, Ying Di, Chun Zhang, & Xiaoliang Cheng. (2022). Measurement of tigecycline in dried blood spots by LC–MS/MS and comparison tigecycline concentrations between whole blood and plasma. Rapid Communications in Mass Spectrometry. 37(1). e9416–e9416. 2 indexed citations
4.
Pike, Jeremy A., Ying Di, Natalie S. Poulter, et al.. (2022). Experimental validation of computerised models of clustering of platelet glycoprotein receptors that signal via tandem SH2 domain proteins. PLoS Computational Biology. 18(11). e1010708–e1010708. 4 indexed citations
5.
Slater, Alexandre, Ying Di, Natalie J. Jooss, et al.. (2021). Structural characterization of a novel GPVI-nanobody complex reveals a biologically active domain-swapped GPVI dimer. Blood. 137(24). 3443–3453. 21 indexed citations
6.
Zuidscherwoude, Malou, et al.. (2021). The structure of CLEC-2: mechanisms of dimerization and higher-order clustering. Platelets. 32(6). 733–743. 20 indexed citations
7.
Bourne, Joshua H., Nonantzin Beristain‐Covarrubias, Malou Zuidscherwoude, et al.. (2021). CLEC-2 Prevents Accumulation and Retention of Inflammatory Macrophages During Murine Peritonitis. Frontiers in Immunology. 12. 693974–693974. 18 indexed citations
8.
Jooss, Natalie J., Yi Sun, Martina Colicchia, et al.. (2021). Galectin‐9 activates platelet ITAM receptors glycoprotein VI and C‐type lectin‐like receptor‐2. Journal of Thrombosis and Haemostasis. 20(4). 936–950. 11 indexed citations
9.
Haining, Elizabeth J., Kate L. Lowe, Surasak Wichaiyo, et al.. (2020). Lymphatic blood filling in CLEC-2-deficient mouse models. Platelets. 32(3). 352–367. 17 indexed citations
10.
Dunster, Joanne L., Amanda J. Unsworth, Alexander P. Bye, et al.. (2019). Interspecies differences in protein expression do not impact the spatiotemporal regulation of glycoprotein VI mediated activation. Journal of Thrombosis and Haemostasis. 18(2). 485–496. 14 indexed citations
11.
Di, Ying, et al.. (2017). The quick loss of carbapenem susceptibility in Pseudomonas aeruginosa at intensive care units. International Journal of Clinical Pharmacy. 40(1). 175–182. 5 indexed citations
12.
Rayes, Julie, Siân Lax, Surasak Wichaiyo, et al.. (2017). The podoplanin-CLEC-2 axis inhibits inflammation in sepsis. Nature Communications. 8(1). 2239–2239. 116 indexed citations
13.
Di, Ying, Maxine Bauzon, Janet Lei-Rossmann, et al.. (2017). Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus. Molecular Therapy — Oncolytics. 5. 62–74. 40 indexed citations
14.
Pollitt, Alice Y., Craig E. Hughes, Ying Di, et al.. (2017). Mouse podoplanin supports adhesion and aggregation of platelets under arterial shear: A novel mechanism of haemostasis. Platelets. 29(7). 716–722. 7 indexed citations
15.
Di, Ying, Hugo Calderón, Gray Kueberuwa, et al.. (2016). Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators. Molecular Therapy — Oncolytics. 4. 18–30. 43 indexed citations
16.
Hills, Thomas, et al.. (2015). Improved In Vitro Human Tumor Models for Cancer Gene Therapy. Human Gene Therapy. 26(5). 249–256. 7 indexed citations
17.
Collins, V. Peter, Koichi Ichimura, Ying Di, et al.. (2014). Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial. Acta Neuropathologica Communications. 2(1). 68–68. 29 indexed citations
18.
Di, Ying, Leonard W. Seymour, & Kerry D. Fisher. (2014). Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood. Gene Therapy. 21(4). 440–443. 29 indexed citations
19.
Qu, Kai, Xinsen Xu, Jie Gao, et al.. (2014). Sclerosing cholangitis in critically ill patients: an important and easily ignored problem based on a German experience. Frontiers of Medicine. 8(1). 118–126. 25 indexed citations
20.
Cawood, Ryan, et al.. (2011). MicroRNA Controlled Adenovirus Mediates Anti-Cancer Efficacy without Affecting Endogenous MicroRNA Activity. PLoS ONE. 6(1). e16152–e16152. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sven Stengel Breakdown of academic impact, for papers by Xiaoming Wu Breakdown of academic impact, for papers by Diana Saleiro Breakdown of academic impact, for papers by Christoffer Soendergaard Breakdown of academic impact, for papers by Mee‐Young Ahn Breakdown of academic impact, for papers by Yueping Sun Breakdown of academic impact, for papers by Xue-Chun Lu Breakdown of academic impact, for papers by Tsuyako Saito Breakdown of academic impact, for papers by Αthanasios Mavropoulos
Rankless by CCL
2026